<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220301054154N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-09-20</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of Fresh Gas Flow on the speed of inhalational induction with sevoflurane in children</public_title>
      <acronym></acronym>
      <scientific_title>The effect of Fresh Gas Flow on the speed of inhalational induction with sevoflurane in children</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-10-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64177</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Through a randomly generated computer-generated list, individuals will be assigned to three intervention groups, Blinding description: In this research only the patient is unaware of the fresh gas flow.</study_design>
      <phase>3</phase>
      <hc_freetext>The effect of Fresh Gas Flow on the speed of inhalational induction with sevoflurane.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: A with FGF of 2 L/min. Intervention 2: Intervention group: B with FGF of 4 L/min. Intervention 3: Intervention group: C with FGF of 6 L/min.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All potential data can be shared after making peoples unrecognizable.

When:
Access period starts 6 months after the results are published

To whom:
The data will be available to researchers working in academia and people in industry.

Conditions:
There are no specific restrictions on the use of data or documentation.

Where to obtain:
Dr .Masoud Parish
Department of Anesthesiology, Faculty of Medicine, Golgasht Street,
Tabriz East Azarbaijan Islamic Republic of Iran
oudparish@yahoo.com
Phone: +98 413 3341994

How to obtain:
Applicants will have access to the data from the present study by sending an email to the responsible author for a maximum of one week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Masoud Parish</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shohada Hospital, Gholshahr Avenue,  Yaghchian street</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5167846171</zip>
        <telephone>+98 41 3385 5842</telephone>
        <email>parishm@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Masoud Parish</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shohada Hospital, Golshahr Avenue, Yaghchian street</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5167846171</zip>
        <telephone>009833855842</telephone>
        <email>parishm@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 6 month to 8 years
candidate for elective orthopedic surgery
having an indication for inhalational induction of anesthesia</inclusion_criteria>
      <agemin>6 months</agemin>
      <agemax>8 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>lack of parental consent
emergent surgery
not being NPO
significant cardiovascular disease
pulmonary disease
neurologic disorder
prediction of a difficult airway or IV line
facial or airway anomalies
history of malignant hyperthermia in the patient or their family
acute respiratory infection in the past week
history of GERD</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T88.59</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other complications of anesthesia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: A with FGF of 2 L/min</i_keyword>
      <i_keyword>Intervention group: B with FGF of 4 L/min</i_keyword>
      <i_keyword>Intervention group: C with FGF of 6 L/min</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Duration of reaching to the Bispectral Index between 60 to 70. Timepoint: from the start point of induction untill reaching to the Bispectral Index between 60 to 70. Method of measurement: using the bispectral index monitor based on electroencephalogram waves during anesthesia, measuring time in seconds.</prim_outcome>
      <prim_outcome>Duration till the loss of response to squeezing the trapezius muscle. Timepoint: from the start point of induction to complete loss of response to squeezing the trapezius muscle. Method of measurement: measuring time in seconds, by physical examination and observing patient's reaction.</prim_outcome>
      <prim_outcome>Duration until Laryngeal Mask Airway installation. Timepoint: from the start point of induction until Laryngeal Mask Airway installation. Method of measurement: measuring time in seconds.</prim_outcome>
      <prim_outcome>Existence of reaction to Laryngeal Mask Airway installation. Timepoint: During Laryngeal Mask Airway insertion. Method of measurement: Observing the patient's reaction.</prim_outcome>
      <prim_outcome>Heart rate. Timepoint: Immediately before induction and one minute after induction and during operation of the Laryngeal Mask Airway. Method of measurement: Beat Per minute using a non-invasive heart rate monitor.</prim_outcome>
      <prim_outcome>Blood pressure. Timepoint: Immediately before induction and one minute after induction and during operation of the Laryngeal Mask Airway. Method of measurement: In millimeters of mercury using a non-invasive method of measuring blood pressure by monitoring device.</prim_outcome>
      <prim_outcome>Oxygen saturation. Timepoint: Immediately before induction and one minute after induction and during operation of the Laryngeal Mask Airway. Method of measurement: in percent, by pulse oximeter device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Breath holding. Timepoint: From the beginning of induction to the end of anesthesia. Method of measurement: observation.</sec_outcome>
      <sec_outcome>Coughing. Timepoint: From the beginning of induction to the end of anesthesia. Method of measurement: observation.</sec_outcome>
      <sec_outcome>Bradycardia. Timepoint: From the beginning of induction to the end of anesthesia. Method of measurement: Beat Per minute using a non-invasive heart rate monitor.</sec_outcome>
      <sec_outcome>Low Blood pressure. Timepoint: From the beginning of induction to the end of anesthesia. Method of measurement: In millimeters of mercury using a non-invasive method of measuring blood pressure by device.</sec_outcome>
      <sec_outcome>Laryngospasm. Timepoint: From the beginning of induction to the end of anesthesia. Method of measurement: observation.</sec_outcome>
      <sec_outcome>Vomiting. Timepoint: From the beginning of induction to the end of anesthesia. Method of measurement: observation.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-09-28</approval_date>
        <contact_name>National committee for ethics in biomedical research (Tabriz university of medical sciences)</contact_name>
        <contact_address>Faculty of medicine, Tabriz university of medical sciences, Golgasht street Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
